Web Analytics

3 Latest Announced Rounds

  • $33,500,000
    Series B

    3 Investors

    Biotechnology Research
    Jan 14th, 2026
  • $1,863,303
    Pre-Seed
    Software Development
    Jan 14th, 2026
  • $5,000,000
    Seed
    Pharmaceutical Manufacturing
    Jan 14th, 2026
$2,290.16M Raised in 46 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Converge Bio

start up
Israel - Tel Aviv District
  • 14/01/2026
  • Series A
  • $25,000,000

Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.